Search results for: 'Complex Drug'

23 Oct 2020  |  North America  |  Market Research

Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

Infographics

×

Key Issues Addressed

In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

Electronic test and measurement instruments are used to capture, process, and display data, signals, electrical parameters. These instruments find significant utilization in research, product development, prototyping, manufacturing, and field testing applications. Electronic test and measurement market participants have continued to invest in the R...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

Amid shifting industry dynamics being driven by decentralization, digitalization, decarbonization and the rise of new business models, the keystone market of industrial automation, lifecycle services, is expected to experience a phase of strong short-term growth. Frost & Sullivans market analysis estimates the market size to grow from $49.56B to $6...

Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

04 Sep 2019  |  North America  |  Market Research

Strategic Analysis of the Global Automation and Control System Market in Life Sciences Industry, 2018

Continuous Manufacturing and Serialization Drive the Market due to the Need for Personalized Medicines

Infographics

×

Key Issues Addressed

The life science industry is on the verge of transformation due to the introduction of new product lines, increasing preference for personalized medicines and localized manufacturing, and high cost pressure. The industry needs the help of digitalization technologies to accelerate the journey of transformation. Increasing focus on improving process ...

Therapeutically more effective drugs for the treatment of chronic diseases represents a crucial need. Biosimilars and biobetters offer the possibility to lower the cost of treating a variety of chronic diseases. In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer per...

22 Jan 2021  |  Global  |  Market Research

Digital Industrial and Energy Guidebook

Future Growth Opportunities and the 2020 Class of Top 50 Supplier Best Practitioners

Infographics

×

The world is facing unrelenting swings that are causing severe uncertainties, volatility, and complexity. As organizations look to cut operational costs and preserve their bottom line, digital transformation is a much sought after aspect to sustain performance. Frost & Sullivan has identified that the digital journey for customers is not a case of ...